Background and Objectives: Human papillomavirus infection has been suggeste
d to play a role in the development of epithelial carcinomas, particularly
those of the uterine cervix. Less information is available on the role of t
he virus in oral lesions. It has been proposed that the viral oncoproteins
specifically complex with the products of cellular tumor suppressor gene, n
amely E6 with p53 and E7 with retinoblastoma gene product. Inactivation or
mutation in p53 gene is also known to result in loss of control over the ce
ll cycle and increases in tumor proliferation rates. The present study exam
ines the role of HPV infection in relation to p53 and the extent of the tum
or proliferative compartment reflected by cyclin D1 and Ki-67 expression du
ring various phases of tumor progression in the oral epithelium.
Method: Nonisotopic in situ hybridization (NISH) was performed to detect HP
V 6/11 and 16/18. Expression of p53, cyclin D1, Ki-67, and the HPV 16/18 E6
protein were detected by immunocytochemistry.
Results: There was significant correlation between the extent of histologic
al abnormality and HPV infection. A correlation (r = 0.250, P = 0.0089) was
evident between the presence of HPV 16 and occurrence of invasive cancer.
Expression of the tumor suppressor p53 protein also showed significant posi
tive correlation with histology (r = 0.475, P = 0.00004). The tumor prolife
rative fraction also increased with the extent of histological abnormality
(r = 0.387, P = 0.0003 for cyclin D1 and r = 0.463, P = 0.0001 for Ki 67).
Accumulation of p53 and increase in tumor proliferation also correlated to
the presence of HPV infection (r = 0.511, P = 0.00003 for p53; r = 0.478, P
= 0.00002 for cyclin D1 and r 0.521, P = 0.00004 for Ki-67).
Conclusions: The present study thus demonstrates the importance of HPV infe
ction in oral tissue. Expression of the high-risk HPV 16/18 E6 protein also
appears to be a critical event along with aberrant p53 expression. These r
esults are of significance to the molecular epidemiology of oral cancer and
may also be used to supplement and elaborate the diagnosis of Oral lesions
. J. Surg. Oncol. 1999;71:10-15. (C) 1999 Wiley-Liss, Inc.